Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. And there is more to consider, since this is an extended break, at least on this side of the pond. Our agenda is rather modest. We plan to spend time with a couple of our short people, catch up on sundry tasks, and take a few naps. And what about you? This may be an opportunity to spend time with someone special, plan a summer getaway, or simply take stock of the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The number of new drugs approved for sale in United States and Europe has bounced back this year, Reuters reports, and the trend suggests a marked slowdown last year was an aberration rather than a sign of flagging research and development productivity. The US Food and Drug Administration has already cleared 21 new prescription medicines for sale against 22 in the whole of 2016, and just nine at this stage last year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • As for the journalist seeking expedited FOIA request: 1) he doesn’t meet the criteria as there are no immediate safety concerns, and 2) does anyone believe this guy will get an expedited approval just so he can write a piece blasting the FDA? Fat chance.

Comments are closed.